166 related articles for article (PubMed ID: 12880291)
1. Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, Part II.
Six K; Berghmans H; Leuner C; Dressman J; Van Werde K; Mullens J; Benoist L; Thimon M; Meublat L; Verreck G; Peeters J; Brewster M; Van den Mooter G
Pharm Res; 2003 Jul; 20(7):1047-54. PubMed ID: 12880291
[TBL] [Abstract][Full Text] [Related]
2. Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion--Part I.
Verreck G; Six K; Van den Mooter G; Baert L; Peeters J; Brewster ME
Int J Pharm; 2003 Jan; 251(1-2):165-74. PubMed ID: 12527186
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole formulation studies of the melt-extrusion process with mixture design.
Rambali B; Verreck G; Baert L; Massart DL
Drug Dev Ind Pharm; 2003 Jul; 29(6):641-52. PubMed ID: 12889782
[TBL] [Abstract][Full Text] [Related]
4. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
Janssens S; de Armas HN; Roberts CJ; Van den Mooter G
J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability.
Lee S; Nam K; Kim MS; Jun SW; Park JS; Woo JS; Hwang SJ
Arch Pharm Res; 2005 Jul; 28(7):866-74. PubMed ID: 16114503
[TBL] [Abstract][Full Text] [Related]
6. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
7. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
[TBL] [Abstract][Full Text] [Related]
8. Dielectric spectroscopy for the determination of the glass transition temperature of pharmaceutical solid dispersions.
O'Donnell KP; Woodward WH
Drug Dev Ind Pharm; 2015 Jun; 41(6):959-68. PubMed ID: 24842545
[TBL] [Abstract][Full Text] [Related]
9. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers.
Six K; Verreck G; Peeters J; Brewster M; Van Den Mooter G
J Pharm Sci; 2004 Jan; 93(1):124-31. PubMed ID: 14648642
[TBL] [Abstract][Full Text] [Related]
10. Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion.
DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
J Pharm Sci; 2010 Mar; 99(3):1239-53. PubMed ID: 19681106
[TBL] [Abstract][Full Text] [Related]
11. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
[TBL] [Abstract][Full Text] [Related]
12. Miscibility of Itraconazole-Hydroxypropyl Methylcellulose Blends: Insights with High Resolution Analytical Methodologies.
Purohit HS; Taylor LS
Mol Pharm; 2015 Dec; 12(12):4542-53. PubMed ID: 26567698
[TBL] [Abstract][Full Text] [Related]
13. Influence of manufacturing factors on physical stability and solubility of solid dispersions containing a low glass transition temperature drug.
Sakurai A; Sako K; Maitani Y
Chem Pharm Bull (Tokyo); 2012; 60(11):1366-71. PubMed ID: 23124559
[TBL] [Abstract][Full Text] [Related]
14. Surface area normalized dissolution to study differences in itraconazole-copovidone solid dispersions prepared by spray-drying and hot melt extrusion.
Bhardwaj V; Trasi NS; Zemlyanov DY; Taylor LS
Int J Pharm; 2018 Apr; 540(1-2):106-119. PubMed ID: 29425762
[TBL] [Abstract][Full Text] [Related]
15. Dissolution enhancement of itraconazole by hot-melt extrusion alone and the combination of hot-melt extrusion and rapid freezing--effect of formulation and processing variables.
Lang B; McGinity JW; Williams RO
Mol Pharm; 2014 Jan; 11(1):186-96. PubMed ID: 24283890
[TBL] [Abstract][Full Text] [Related]
16. Part I: characterization of solid dispersions of nimodipine prepared by hot-melt extrusion.
Zheng X; Yang R; Tang X; Zheng L
Drug Dev Ind Pharm; 2007 Jul; 33(7):791-802. PubMed ID: 17654028
[TBL] [Abstract][Full Text] [Related]
17. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
[TBL] [Abstract][Full Text] [Related]
18. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
Sarode AL; Sandhu H; Shah N; Malick W; Zia H
Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
[TBL] [Abstract][Full Text] [Related]
19. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
Zecevic DE; Meier R; Daniels R; Wagner KG
Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
[TBL] [Abstract][Full Text] [Related]
20. Physical stability of ternary solid dispersions of itraconazole in polyethyleneglycol 6000/hydroxypropylmethylcellulose 2910 E5 blends.
Janssens S; Roberts C; Smith EF; Van den Mooter G
Int J Pharm; 2008 May; 355(1-2):100-7. PubMed ID: 18191508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
